scPharmaceuticals Inc. announced at its 2018 annual meeting of stockholders that Frederick M. Hudson was elected to the company’s Board of Directors, replacing Abhay Gandhi, whose term on the Board ended. Mr. Hudson will act as an independent director and Chair the Audit Committee. Mr. Hudson brings to the company board over 37 years of relevant experience in accounting and auditing as a longtime partner at KPMG, LLP. Prior to his retirement, Mr. Hudson was the partner in charge of KPMG’s healthcare industry audit practice located in the Mid-Atlantic region. Over his career, Mr. Hudson also held senior positions with KPMG in the area of due-diligence and mergers and acquisitions services where his work was focused on high-growth companies in the healthcare industry. Over the last twelve years, Mr. Hudson has been a director of a variety of public and private healthcare industry companies.